Clinical trials: Vasculogenic Erectile Dysfunction
Erectile Dysfunction
Clinical Trial to Evaluate the Efficacy of Intracavernosal Infusion of PRP vs PPP for the Erectile Dysfunction.
Randomized, double-blind clinical trial to evaluate efficacy, feasibility and safety with two groups in a 1:1 ratio; where the control group corresponds to patients who will receive Platelet Poor plasma and an experimental group…
- Trial name
- PRePED (NCT04502875)
- Testing
- PRP, PPP
- Where
- Spain
- Volunteers
- 52 people
- Sponsor
- Puerta de Hierro University Hospital
Erectile Dysfunction
Sirolimus Eluting Balloon Utilization for Treatment of Vasculogenic Erectile Dysfunction
Brief Summary: Background and pathophysiology: Erectile dysfunction (ED) is defined as the recurrent inability to achieve and maintain an erection satisfactory for sexual intercourse.
- Trial name
- SUASION (NCT04345965)
- Testing
- Endovascular procedure
- Where
- Italy
- Volunteers
- 100 people
- Sponsor
- Clinica San Gaudenzio
Erectile Dysfunction (ED)
The Feasibility of Using Dornier Machine in Patients With Erectile Dysfunction, a Pilot Study.
Extracorporeal Shockwave Therapy (ESWT) is a well-established modality for treating various urological and musculoskeletal conditions.
- Trial name
- DED-Pilot (NCT07331961)
- Testing
- extracorporeal shock wave therpy
- Volunteers
- 30 people, healthy volunteers welcome
- Sponsor
- Assiut University
Vasculogenic Erectile Dysfunction
Intracavernosal Injection of Botulinum Toxin Type A in the Treatment of Vascular Erectile Dysfunction
Evidence has been arising that Botulinum toxin injections can relax smooth muscles fibers in the treatment of obesity and hyperactive bladder.
- Trial name
- NCT02584686
- Testing
- Botulinum Toxin Type A, Normal Saline
- Where
- Egypt
- Volunteers
- 24 people, healthy volunteers welcome
- Sponsor
- Cairo University
Erectile Dysfunction, Low Intensity Shockwave Therapy
Low-intensity Shockwave Therapy (LiST) for the Treatment of Mild and Mild-to-moderate Vasculogenic Erectile Dysfunction
This is a randomized, double-blind, 2 parallel arms clinical trial. All patients will be PDE5I users/responders. After 1 month wash-out period, ED patients will be screened, in order to randomize 50 men with vasculogenic ED with…
- Trial name
- NCT03641846
- Testing
- DornierAries2 LiST device + 5 mg Tadalafil
- Where
- Greece
- Volunteers
- 50 people
- Sponsor
- Institute for the Study of Urological Diseases, Greece
Erectile Dysfunction
Low-intensity Shockwaves Therapy + Tadalafil 5mg for the Treatment of Severe Erectile Dysfunction
This is a randomized, double-blind, sham-controlled, 3 parallel arms, clinical trial. All patients will be PDE5I users or ex-users.
- Trial name
- NCT03642366
- Testing
- Dornier Aries2 LiST Device + 5mg Tadalafil (1), Dornier Aries2 LiST Device + 5mg Tadalafil (2)
- Where
- Greece
- Volunteers
- 51 people
- Sponsor
- Institute for the Study of Urological Diseases, Greece
Erectile Dysfunction
Low-intensity Shockwaves Therapy for the Treatment of Patients With Moderate Vasculogenic Erectile Dysfunction
This is a double-blind, sham-controlled randomized, 2 parallel arms, clinical trial with a 12-month recruitment period. All patients will be PDE5I users/responders.
- Trial name
- NCT03518983
- Testing
- Dornier Aries2 device
- Where
- Greece
- Volunteers
- 70 people
- Sponsor
- Institute for the Study of Urological Diseases, Greece
Vasculogenic Erectile Dysfunction
Safety and Efficacy of Low Intensity Shockwave for the Treatment of Erectile Dysfunction
Renova- Erectile Dysfunction (ED) is a Linear Shockwaves (LISW) device which incorporates a unique shockwave transducer operable to deliver shockwaves to a treated region.
- Trial name
- NCT03067987
- Testing
- Low Intensity Linear Shockwave Device for the Treatment of Erectile Dysfunction.
- Where
- United States
- Volunteers
- 103 people
- Sponsor
- University of Miami
Evaluation of the Relationship Between Serum Biomarkers (Endocan and ADMA) and Penile Doppler Ultrasonography Findings of Patients With Severe Erectile Dysf
The Relationship Between Serum Endocan and ADMA Levels and Penile Doppler Ultrasonography in Erectile Dysfunction
The gold standard diagnosis in patients admitted to the hospital with the complaint of erectile dysfunction is penile doppler ultrasonography. This procedure is an invasive procedure and can cause various complications.
- Trial name
- NCT05979467
- Where
- Turkey (Türkiye)
- Volunteers
- 73 people
- Sponsor
- Ankara Etlik City Hospital
Erectile Dysfunction, Impotence, Vasculogenic
Effectiveness and Safety of Adipose-Derived Regenerative Cells for Treatment of Erectile Dysfunction
Autologous adipose-derived regenerative cells (ADRC) extracted using Celution 800/CRS System (Cytori Therapeutics Inc) from a portion of the fat harvested from the patient's front abdominal wall.
- Trial name
- NCT02472431
- Testing
- Intracavernosal administration of autologous ADRC, Liposuction, ADRC isolation
- Where
- 2 sites in Russia
- Volunteers
- 12 people
- Sponsor
- Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation
Vasculogenic Erectile Dysfunction
Safety and Efficacy Associated With Treating Erectile Dysfunction Patients With Low Intensity Shockwaves by Renova
This is a prospective, randomized, double-blind clinical study comparing safety and efficacy of the treatments performed with the Low Intensity Extracorporeal Shockwave Therapy (LI-ESWT) device - "Renova" on symptomatic ED…
- Trial name
- NCT01811797
- Testing
- Low Intensity Shockwave by Renova
- Where
- Israel
- Volunteers
- 2 people
- Sponsor
- Initia
Erectile Dysfunction, Sexual Dysfunction, Physiological
ARIES for Vasculogenic Erectile Dysfunction
This study aims to evaluate the safety and efficacy of low-intensity extracorporeal shock wave therapy utilizing the Dornier Aries in the treatment of erectile dysfunction of vasculogenic origin.
- Trial name
- AriesIDE#1 (NCT02620982)
- Testing
- ARIES (Extracorporal Shock Wave Application)
- Where
- United States
- Volunteers
- 23 people
- Sponsor
- Dornier MedTech Systems
Erectile Dysfunction
Low Intensity Extracorporeal Shock Wave Treatment for Erectile Dysfunction: Standardisation of Treatment Protocol
The present study aims to identify the efficacy saturation effect of low intensity extracorporeal shockwave treatment (LI-ESWT) using Aries ED device in men with mild-moderate and severe vasculogenic ED, who have previously…
- Trial name
- NCT03089294
- Testing
- Aries ED device
- Where
- Greece
- Volunteers
- 96 people
- Sponsor
- Institute for the Study of Urological Diseases, Greece
Vasculogenic Erectile Dysfunction
Low Intensity Extracorporeal Shockwave Therapy (LI-ESWT) by 'Renova' for Patients With Erectile Dysfunction
This is a prospective, randomized, double-blind clinical study for assessing the safety and efficacy of the treatments performed with Renova (LI-ESWT) on symptomatic ED patients.
- Trial name
- NCT01814852
- Testing
- Shockwave system
- Where
- Israel
- Volunteers
- 60 people
- Sponsor
- Initia
Vasculogenic Erectile Dysfunction
Linear Focused Shockwave Treatment for Erectile Dysfunction
The study is aimed at comparing the performance of protocols employing one and two sessions per week, respectively. The study hypothesis claims that there is no significant difference between the performances of the compared…
- Trial name
- NCT02152683
- Testing
- Renova
- Where
- United States
- Volunteers
- 84 people
- Sponsor
- Initia
Vasculogenic Erectile Dysfunction
Low Intensity Extracorporeal Shockwave Therapy for Patients With Erectile Dysfunction
This is a prospective, pilot study for assessing the safety and efficacy of the treatments performed with Renova (LI-ESWT) on symptomatic ED patients.
- Trial name
- LISW (NCT02005731)
- Testing
- Low intensity linear focused shockwave device ('Renova')
- Where
- 4 sites in Czechia, Lithuania and 2 more
- Volunteers
- 58 people
- Sponsor
- Initia
Erectile Dysfunction
Atherogenic Index of Plasma and Tadalafil Response in Erectile Dysfunction
This prospective single-center observational cohort study examined whether baseline atherogenic index of plasma (AIP), calculated from routine triglyceride and high-density lipoprotein cholesterol measurements, was associated…
- Trial name
- NCT07479901
- Testing
- tadalafil
- Where
- Turkey (Türkiye)
- Volunteers
- 176 people
- Sponsor
- Taksim Egitim ve Arastirma Hastanesi
Erectile Dysfunction
Effect of Repeating Low Intensity Extracorporeal Shock Wave Treatment (LI-ESWT) for Erectile Dysfunction (ED)
The present study evaluates the efficacy and safety of repetitive treatments of Low Intensity Extracorporeal Shock Wave Treatment (LI-ESWT) using Aries ED device in men with mild-moderate and severe vasculogenic ED, who have…
- Trial name
- NCT03089372
- Testing
- ARIES-ED device
- Where
- Greece
- Volunteers
- 36 people
- Sponsor
- Institute for the Study of Urological Diseases, Greece
Vasculogenic Erectile Dysfunction
Low Intensity Linear Shockwave Therapy for Erectile Dysfunction
MoreNovaED is a Linear Shockwaves (LISW) device in which shockwaves are focused onto line segments for improved organ coverage. Shockwaves produced by MoreNovaED are aimed at the left and right corpora cavernosa and the crura.
- Trial name
- NCT03843086
- Testing
- Low Intensity Linear Shockwave Device for the treatment of Erectile Dysfunction
- Sponsor
- University of Virginia
Impotence, Arteriogenic
Bioabsorbable Everolimus-Eluting Stents for Internal Pudendal Artery-Related Arteriogenic Erectile Dysfunction
In this prospective, unblinded, single-arm, single-center study, investigators would like to assess the feasibility and safety of the bioabsorbable everolimus-eluting stents in patients with erectile dysfunction and concomitant…
- Trial name
- NCT02492386
- Testing
- Bioabsorbable everolimus-eluting stent deployment
- Volunteers
- 15 people
- Sponsor
- National Taiwan University Hospital